Cargando…
Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials
For decades, plasma arginine vasopressin (AVP) levels have been known to be elevated in patients with congestive heart failure (HF). Excessive AVP signaling at either or both the V1a and V2 receptors could contribute to the pathophysiology of HF by several mechanisms. V1a activation could cause vaso...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809578/ https://www.ncbi.nlm.nih.gov/pubmed/33435837 http://dx.doi.org/10.1177/1753944720977741 |